# Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)

> **NCT01028287** · PHASE4 · COMPLETED · sponsor: **Southeast Renal Research Institute** · enrollment: 15 (actual)

## Conditions studied

- Diabetic Nephropathy
- Nephrotic Syndrome

## Interventions

- **DRUG:** ACTH
- **DRUG:** ACTH

## Key facts

- **NCT ID:** NCT01028287
- **Lead sponsor:** Southeast Renal Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-12
- **Final completion:** 2011-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2013-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01028287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01028287, "Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01028287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*